Product Code: VMR112113534
The global demand for Cell Cryopreservation Market is presumed to reach the market size of nearly USD 70.53 Billion by 2032 from USD 11.65 Billion in 2023 with a CAGR of 22.15% under the study period 2024 - 2032.
Cell cryopreservation is a technique used to preserve cells by freezing them at very low temperatures, typically in liquid nitrogen (-196 degrees Celsius or -321 degrees Fahrenheit) or in specialized cryopreservation solutions. This process allows cells to be stored for extended periods while maintaining their viability and functionality.
MARKET DYNAMICS
The Cell cryopreservation market is thriving due to the escalating importance of preserving cell viability across diverse applications. Medical advancements in organ transplantation, regenerative medicine, and assisted reproductive technologies are driving the adoption of cryopreservation for cells, particularly stem cells. The expansion of biobanks and their pivotal role in supporting research in cancer, genetics, and drug development significantly contributes to market growth. The continuous growth of assisted reproductive technologies, the development of cell-based therapies, and the integral role of cryopreserved cells in biopharmaceutical production are key drivers. Increased investments in research and development, coupled with technological advancements in cryopreservation methods, fuel demand. Cryopreservation's crucial role in conservation efforts, preventing the extinction of endangered species, adds to market dynamics. Furthermore, the globalization of healthcare, the rise in chronic diseases, and the impact of the COVID-19 pandemic on biotechnological solutions emphasize the market's significance. The Cell cryopreservation market is poised for continued expansion, underlining its critical role in advancing medical treatments, research, and biotechnological applications.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell cryopreservation. The growth and trends of cell cryopreservation industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the cell cryopreservation market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
- Cryoprotectant Agents (Dimethyl Sulfoxide (DMSO), Ethylene Glycol, Glycerol, Other Agents)
- Equipment (Freezers, Incubators, Liquid Nitrogen Supply Tanks, Cryopreservation Consumables)
By Cell Type
- Stem Cells
- Oocytes And Embryotic Cells
- Sperm Cells
- Hepatocytes
- Other
By Application
- Drug Discovery And Development
- Regenerative Medicine
- Organ Transplantation
- Clinical Research
- Other
By End-Use
- Hospitals And Clinics
- Biotechnology And Pharmaceutical Companies
- Research And Academic Institutes
- Contract Research Organizations (CROs)
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Cell Cryopreservation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Cryopreservation market include Thermo Fisher Scientific Inc., Sartorius AG, PromoCell GmbH, BioLife Solutions Inc., Merck KGaA, HiMedia Laboratories, Creative Biolabs, Corning Incorporated, GE Healthcare, Danaher Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . CELL CRYOPRESERVATION - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Cell Type
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY PRODUCT TYPE
- 5.1 Overview by Product Type
- 5.2 Historical and Forecast Data
- 5.3 Analysis by Product Type
- 5.4 Cryoprotectant Agents (Dimethyl Sulfoxide (DMSO), Ethylene Glycol, Glycerol, Other Agents) Historic and Forecast Sales by Regions
- 5.5 Equipment (Freezers, Incubators, Liquid Nitrogen Supply Tanks, Cryopreservation Consumables) Historic and Forecast Sales by Regions
6 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY CELL TYPE
- 6.1 Overview by Cell Type
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Cell Type
- 6.4 Stem Cells Historic and Forecast Sales by Regions
- 6.5 Oocytes And Embryotic Cells Historic and Forecast Sales by Regions
- 6.6 Sperm Cells Historic and Forecast Sales by Regions
- 6.7 Hepatocytes Historic and Forecast Sales by Regions
- 6.8 Other Historic and Forecast Sales by Regions
7 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY APPLICATION
- 7.1 Overview by Application
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Application
- 7.4 Drug Discovery And Development Historic and Forecast Sales by Regions
- 7.5 Regenerative Medicine Historic and Forecast Sales by Regions
- 7.6 Organ Transplantation Historic and Forecast Sales by Regions
- 7.7 Clinical Research Historic and Forecast Sales by Regions
- 7.8 Other Historic and Forecast Sales by Regions
8 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY END-USE
- 8.1 Overview by End-use
- 8.2 Historical and Forecast Data
- 8.3 Analysis by End-use
- 8.4 Hospitals And Clinics Historic and Forecast Sales by Regions
- 8.5 Biotechnology And Pharmaceutical Companies Historic and Forecast Sales by Regions
- 8.6 Research And Academic Institutes Historic and Forecast Sales by Regions
- 8.7 Contract Research Organizations (CROs) Historic and Forecast Sales by Regions
9 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY GEOGRAPHY
- 9.1. Regional Outlook
- 9.2. Introduction
- 9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
- 9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
- 9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. South East Asia Sales Analysis
- 9.5.10. Rest Of Asia Pacific Sales Analysis
- 9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
- 9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis
10 . COMPETITIVE LANDSCAPE OF THE CELL CRYOPRESERVATION COMPANIES
- 10.1. Cell Cryopreservation Market Competition
- 10.2. Partnership/Collaboration/Agreement
- 10.3. Merger And Acquisitions
- 10.4. New Product Launch
- 10.5. Other Developments
11 . COMPANY PROFILES OF CELL CRYOPRESERVATION INDUSTRY
- 11.1. Company Share Analysis
- 11.2. Market Concentration Rate
- 11.3. Thermo Fisher Scientific Inc.
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
- 11.4. Sartorius AG
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
- 11.5. PromoCell GmbH
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
- 11.6. BioLife Solutions Inc.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
- 11.7. Merck KGaA
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
- 11.8. HiMedia Laboratories
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
- 11.9. Creative Biolabs
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
- 11.10. Corning Incorporated
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
- 11.11. GE Healthcare
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
- 11.12. Danaher Corporation
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies